---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-033139"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2023-09-20T23:59:59+00:00"
generated_at: "2026-06-10T12:07:53.755051+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biotricity raises $2M via Series B Convertible Preferred Stock at $3.50 conversion price, 8% dividend

## Summary
- Gross proceeds of $2,000,000 from sale of 220 Series B Preferred shares at $9,090.91 per share.
- Series B Preferred carries 8% cumulative dividend, increasing to 15% upon a triggering event.
- Initial conversion price set at $3.50 per share; alternate conversion at 80% of lowest VWAP.
- Company may redeem shares at 110% of stated value; holders can force redemption upon a trigger event.
- Institutional investor subject to 4.99% beneficial ownership cap; shareholder vote may be needed if conversion exceeds 19.9% of outstanding common.

## SEC filing metadata
- accession: 0001493152-23-033139
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2023-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315223033139/0001493152-23-033139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315223033139/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-033139
- JSON: https://secwatch.observer/filing/0001493152-23-033139.json
- Plain text: https://secwatch.observer/filing/0001493152-23-033139.txt

## Key facts
- Material Agreements
  BIOTRICITY INC. entered into Purchase Agreement with an institutional investor valued at $2,000,000 (effective 2023-09-19).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an institutional investor
  - Value: $2,000,000
  - Effective: 2023-09-19
  source text: On September 19, 2023, Biotricity Inc. (the “Company”) entered into a security purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the issuance and sale of 220 shares of the Company’s newly designated Series B Convertible Preferred Stock, $0.001 par value (the “Series B Preferred Stock”), at a purchase price of $9,090.91 per share of Preferred Stock, or gross proceeds of $2,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315223033139/0001493152-23-033139-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.